DEEP Diagnostics is an Inspire2Live lighthouse project created to provide a personalised individual treatment and medicine plan i.e., this patient, with their specific disease, at this moment, needs this particular treatment.
We’ve created a diagnostic toolbox by combining Whole Genome Sequencing with drug screening. We identify the DNA mutation and we test the medicines via drug screening ex-vivo (on patient tissue outside the body) so that we can determine what works and what doesn’t.
As part of our project, we have started working with patients suffering from a type of brain tumour known as glioblastoma and with patients diagnosed with pancreatic cancer. These two unmet medical needs deserve so much more attention than they have received until now.
Inspire2Live is currently raising the funding and we hope to launch in Q4 2023. The project will run for 30 months (6 months of preparation and 24 months of execution) and, once the project has been completed, we will know whether it is possible to define a more individually tailored treatment or not. At Inspire2Live we are convinced that we can do much better with tools which are already available.
